FTSE 100 movers: BP boosted by lower-than-expected fine, ARM hit by Intel competition
Oil giant BP was among the risers after the company revealed it faces a maximum penalty of $13.7bn under the Clean Water Act. This follows the District Court for the Eastern District of Louisiana ruling on the Deepwater Horizon case, which found that 3.19m barrels of oil were discharged in the Gulf of Mexico in 2010. The bill, which was some $4bn less than feared, put the spill's size below the government's 4.09m estimate and just under the 3.26m estimated by the firm.
ARM Holdings
1,700.00p
17:09 02/09/16
AstraZeneca
9,990.00p
15:45 15/11/24
BHP Group Limited NPV (DI)
2,056.00p
15:45 15/11/24
BP
384.00p
15:45 15/11/24
BT Group
142.10p
15:45 15/11/24
Fixed Line Telecommunications
1,994.59
15:44 15/11/24
FTSE 100
8,060.61
15:45 15/11/24
FTSE 350
4,453.56
15:45 15/11/24
FTSE All-Share
4,411.85
15:45 15/11/24
Imperial Brands
2,370.00p
15:45 15/11/24
Mining
10,633.77
15:45 15/11/24
Oil & Gas Producers
8,043.72
15:45 15/11/24
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
Technology Hardware & Equipment
1,920.18
16:30 25/09/24
Tobacco
33,072.47
15:45 15/11/24
Sector peer BHP Billiton was also up, after oil prices advanced on Friday morning. Brent futures were up 2.6% at $49.50 a barrel after the International Energy Agency (IEA) said a turnaround could be on the horizon. "A price recovery - barring any major disruption - may not be imminent, but signs are mounting that the tide will turn. A rebalancing may begin to occur in the second half of the year,” the IEA said, as it lowered its forecasts for non-OPEC supply.
Imperial Tobacco’s share prices were boosted as Morgan Stanley hiked its target price from 2,680p to 3,250p and named the stock its new top pick, saying it is “increasingly optimistic” about its pending $7bn acquisition of assets from Reynolds and Lorillard.
BT Group shares were also higher after being upgraded from ‘hold’ to ‘buy’ by Societe Generale.
Meanwhile ARM Holdings took a hit after US chip rival Intel revealed it had sold more-than-expected chips for tablets in 2014 on Thursday night. Liberum kept a ‘sell’ rating on ARM, saying that competition from Intel is now rising in the smartphone sector, “which could take share from ARM in its core market”.
AstraZeneca was falling following a downgrade from Barclays Capital from ‘equal weight’ to ‘underweight’. The broker said: "In an interview with The Times late last year CEO Pascal Soriot urged investors to not fixate on the Long-Range Plan central to its bid defence against Pfizer and to focus instead on margins. We view this as a tacit admission that management's $45 bn 2023 revenue projection is unrealistic and we view 2017 revenue guidance as equally unlikely to be met."
Risers
Experian (EXPN) 1,162.00p +3.66%
Antofagasta (ANTO) 688.50p +2.76%
BP (BP.) 403.40p +2.75%
Glencore (GLEN) 247.05p +2.68%
Anglo American (AAL) 1,087.00p +2.60%
BG Group (BG.) 836.90p +2.01%
BT Group (BT.A) 407.80p +1.90%
BHP Billiton (BLT) 1,373.50p +1.89%
Imperial Tobacco Group (IMT) 2,904.00p +1.89%
Standard Life (SL.) 392.20p +1.24%
Fallers
easyJet (EZJ) 1,600.00p -2.74%
Wolseley (WOS) 3,601.00p -2.54%
Mondi (MNDI) 1,052.00p -2.41%
Dixons Carphone (DC.) 424.30p -2.33%
ARM Holdings (ARM) 974.00p -2.16%
Babcock International Group (BAB) 1,003.00p -1.57%
AstraZeneca (AZN) 4,661.50p -1.43%
Burberry Group (BRBY) 1,661.00p -1.37%
Persimmon (PSN) 1,436.00p -1.37%
Meggitt (MGGT) 511.00p -1.35%